Delivery Order SPE2DR25D2212-SPE2DR26FB9HF
- Not listed
- The Defense Logistics Agency awarded a $11,097.32 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 23, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $116,824.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) with an ultimate completion date of December 2, 2025. This competitively awarded contract, without set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $7,668.28 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) with a completion date of November 17, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary operations for federal...
- The Defense Logistics Agency awarded a $11,522.91 delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on September 12, 2025, with completion scheduled for September 15, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $32,178.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units) on December 1, 2025, with completion scheduled for December 2, 2025. This non-set-aside award was issued from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $31,540.49 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $11,207.26 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on October 31, 2025, with a completion date of November 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $5,607.60 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a completion date of November 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract action under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on September 24, 2025, with a ceiling value of $26,026.55. This is a firm fixed-price delivery order with no set-aside designation, executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $13,303.24 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count), with an ultimate completion date of November 25, 2025. This is a firm fixed price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9HFDelivery Order
The Defense Logistics Agency awarded a $74,312.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with an ultimate completion date of November 25, 2025. This contract was competitively awarded with no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement. The Trelegy Ellipta inhaler is a combination respiratory medication used in treating chronic obstructive pulmonary disease, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The underlying IDC vehicle enables flexible procurement of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally, with DLA planning to establish additional regional Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $74.3k | 11/23/25 |